Evidence map›Paper›PMID 40261073›Full record

ArticleAntimicrobial agents and chemotherapy2025

Emergence of KPC-8-producing

María Alejandra Mateo-Vargas, Salud Rodríguez-Pallares, Jorge Arca-Suárez, Lorena López-Cerero, Manuel Rodríguez-Iglesias, Fátima Galán-Sánchez

Abstract readCase Reports
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Emergence and dissemination ofMicrobiology spectrum · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

María Alejandra Mateo-VargasDepartamento de Biomedicina, Biotecnología y Salud Pública, Universidad de Cádiz, Cadiz, Spain.ORCID 0000-0003-0854-9703
Salud Rodríguez-PallaresServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña (Spain), A Coruña, Spain.
Jorge Arca-SuárezServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña (Spain), A Coruña, Spain.
Lorena López-CereroCIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0001-8950-4384
Manuel Rodríguez-IglesiasDepartamento de Biomedicina, Biotecnología y Salud Pública, Universidad de Cádiz, Cadiz, Spain.
Fátima Galán-SánchezServicio de Microbiología and Instituto de Innovación e Investigación Biomédica de Cádiz (INIBICA), Hospital Universitario Puerta del Mar, Cadiz, Spain.ORCID 0000-0003-0101-6701

Funding

Axencia Galega de Innovación CB21/13/00055Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CIBERINFEC) CB21/13/00055Instituto de Salud Carlos III JR21/00026Instituto de Salud Carlos III PI22/01212Menarini Group (Menarini Ricerche SpA)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCeftazidimeKlebsiella InfectionsKlebsiella pneumoniaeAdultBoronic AcidsCarbapenemsCefiderocolCephalosporinsDrug CombinationsDrug Resistance, Multiple, BacterialEscherichia coliHeterocyclic Compounds, 1-RingAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesBoronic AcidscarbapenemaseCarbapenemsCefiderocolCeftazidimeCephalosporinsDrug CombinationsHeterocyclic Compounds, 1-RingImipenemMeropenemmeropenem and vaborbactamrelebactamantimicrobial resistancecefiderocolceftazidime/avibactamevolutionimipenem/relebactamKlebsiella pneumoniaeKPC-31KPC-8meropenem/vaborbactamβ-lactamase

Identifiers

PMID40261073
PMCPMC12135529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.